메뉴 건너뛰기




Volumn 9, Issue 11, 2010, Pages 841-

Cancer: Targeting mutant BRAF in metastatic melanoma

(1)  Flemming, Alexandra a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; B RAF KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

EID: 78049469740     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3304     Document Type: Article
Times cited : (7)

References (3)
  • 1
    • 77956513286 scopus 로고    scopus 로고
    • Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
    • Bollag, G. et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467, 596-599 (2010)
    • (2010) Nature , vol.467 , pp. 596-599
    • Bollag, G.1
  • 2
    • 77954376912 scopus 로고    scopus 로고
    • V600E inhibitor, displays potent antitumor activity in preclinical melanoma models
    • V600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Cancer Res. 70, 5518-5527 (2010)
    • (2010) Cancer Res. , vol.70 , pp. 5518-5527
    • Yang, H.1
  • 3
    • 77956030786 scopus 로고    scopus 로고
    • Inhibition of mutated, activated BRAF in metastatic melanoma
    • Flaherty, K. et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl J. Med. 363, 809-819 (2010)
    • (2010) N. Engl J. Med. , vol.363 , pp. 809-819
    • Flaherty, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.